Key facts
- Notable investors include SIAT Institute.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bloomage Gag
- ·The full record, as it builds
Funding rounds
No funding rounds for Bloomage Gag are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bloomage Gag
Manufacturer of a biotechnology intended to advance glycoscience and regenerative medicine through innovative biomanufacturing. The company offers proprietary enzyme technologies, advanced 3D skin modeling, and expertise in hyaluronic acid and glycobiology, enabling pharmaceutical, aesthetic, and biomedical industries, enhanced product efficacy, precision delivery, and accelerated clinical development.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2023
- Website
- bloomagegag.com/
- Ownership
- Privately Held (backing)
Bloomage Gag doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bloomage Gag shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bloomage Gag in its N-PORT filings yet. We sweep new filings monthly.